Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion type Assertion NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_head.
- NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_provenance.
- NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion evidence source_evidence_literature NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_provenance.
- NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion SIO_000772 21667112 NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_provenance.
- NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion wasDerivedFrom befree-20140225 NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_provenance.
- NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion wasGeneratedBy ECO_0000203 NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_provenance.